Bicycle Therapeutics (BCYC) Other Non Operating Income (2018 - 2026)

Bicycle Therapeutics posted quarterly Other Non Operating Income of $107000.0 for Q1 2026, up 153.77% year-on-year from $42164.4 in Q1 2025, and up 2775.0% on a QoQ basis from -$4000.0 in Q4 2025.

Bicycle Therapeutics (BCYC) has 5 years of Other Non Operating Income data on file, last reported at $107000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non Operating Income rose 153.77% year-over-year to $107000.0; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 219.19% YoY), and the FY2025 full-year result was $700000.0, up 200.0% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at $107000.0, up from -$4000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $745000.0 in Q2 2025 and bottomed at -$1.0 million in Q3 2024.
  • The 3-year median for Other Non Operating Income is $101000.0 (2024), against an average of $25888.9.
  • Peak annual rise in Other Non Operating Income reached 637.62% in 2025, while the deepest fall reached 380.28% in 2025.
  • A 3-year view of Other Non Operating Income shows it stood at $254000.0 in 2024, then sank by 101.57% to -$4000.0 in 2025, then jumped by 2775.0% to $107000.0 in 2026.
  • The last three Other Non Operating Income figures came in at $107000.0 (Q1 2026), -$4000.0 (Q4 2025), and $158000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Bicycle Therapeutics 326.82 Mn 326.82 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 107,000.00
Dec 31, 2025 -4,000.00
Sep 30, 2025 158,000.00
Jun 30, 2025 745,000.00
Mar 31, 2025 -199,000.00
Dec 31, 2024 254,000.00
Sep 30, 2024 -1.00 Mn
Jun 30, 2024 101,000.00
Mar 31, 2024 71,000.00
Jun 30, 2019 -2.18 Mn
Mar 31, 2019 -3.19 Mn
Dec 31, 2018 807,000.00
Sep 30, 2018 -1.36 Mn
Jun 30, 2018 -73,000.00